Cost-Effectiveness of Drug Therapy for Hypercholesterolaemia

The Lipid Research Clinics Coronary Primary Prevention Trial Results

1984 • 2,673 citations

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1977 • 2,113 citations

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1984 • 631 citations

Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease

1991 • 354 citations

Long-term Cost-effectiveness of Various Initial Monotherapies for Mild to Moderate Hypertension

1990 • 271 citations

Cost-Effectiveness of Interventions to Prevent or Treat Coronary Heart Disease

1985 • 226 citations

Cost-effectiveness of Antihyperlipemic Therapy in the Prevention of Coronary Heart Disease

1987 • 176 citations

Cost-effectiveness of Nicotine Gum as an Adjunct to Physician's Advice Against Cigarette Smoking

1986 • 171 citations

Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia

1988 • 160 citations

Principles of Pharmacoeconomic Analysis of Drug Therapy

1992 • 147 citations

Reducing High Blood Cholesterol Level With Drugs

1990 • 124 citations

Cutting Into Cholesterol

1988 • 114 citations

The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal

1991 • 92 citations

Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol.

1986 • 80 citations

Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?

1991 • 77 citations

An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction

1991 • 73 citations

Cholesterol, Children, and Heart Disease: An Analysis of Alternatives

1981 • 70 citations

Cost effectiveness of cholesterol-lowering therapy in The Netherlands

1989 • 55 citations

Policy Analysis, Inc.

1988 • 54 citations

A Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering Treatment

1992 • 54 citations

Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The Netherlands

1990 • 53 citations

Chapter 1 Introduction

1990 • 48 citations

Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older Americans

1991 • 45 citations

Practice Guidelines and Cholesterol Policy

1991 • 34 citations

Free Care, Cholestyramine, and Health Policy

1984 • 34 citations

Costs and benefits of risk factor reduction for coronary heart disease: Insights from screening and treatment of serum cholesterol

1990 • 23 citations

Simvastatin

1992 • 21 citations

Primary Prevention of Coronary Heart Disease in the Federal Republic of Germany

1990 • 20 citations

Screening for hypercholesterolemia among Canadians: how much will it cost?

1991 • 20 citations

12 The economics of cholesterol lowering

1990 • 12 citations

Gemfibrozil Cost-Benefit Study

1990 • 10 citations

Hypercholesterolemia: the cost of treatment in perspective.

1990 • 7 citations

Asymptomatic hypercholesterolemia: a clinical policy review. The Toronto Working Group on Cholesterol Policy.

1990 • 7 citations

Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.

1987 • 7 citations

Economic factors in formulating a national policy on the prevention by drugs of cardiovascular disease.

1990 • 6 citations